CASI Pharmaceuticals
CASI
CASI
38 hedge funds and large institutions have $11.8M invested in CASI Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.16% more ownership
Funds ownership: 0.4% → 0.55% (+0.16%)
Holders
38
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.88M | |
| 2 | +$608K | |
| 3 | +$308K | |
| 4 |
PA
Perceptive Advisors
New York
|
+$272K |
| 5 |
Barclays
London,
United Kingdom
|
+$217K |
Top Sellers
| 1 | -$146K | |
| 2 | -$113K | |
| 3 | -$92.3K | |
| 4 |
HCM
Howland Capital Management
Boston,
Massachusetts
|
-$43K |
| 5 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$27K |